Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Surg Oncol. 2016 Apr 13;114(1):56–64. doi: 10.1002/jso.24256

Table 1.

Retroperitoneal Sarcoma Patient Characteristics

Variable (n) Number % Percent
Sex
 Male 63 48.1
 Female 68 51.9

Age at Diagnosis
 < 60 66 50.4
 ≥ 60 65 49.6

Year of Diagnosis
 1994 – 1999 33 25.2
 2000 – 2005 52 39.7
 2006 – 2010 46 35.1

Surgical Resection
 No 16 12.2
 Yes 115 87.8

Radiation Therapy
 No 100 76.3
 Yes 31 23.7

Chemotherapy
 No 94 71.8
 Yes 37 28.2

Metastasis at Presentation
 No 108 82.4
 Yes 23 17.6

 Mets and Surgery
  No 9 39.1
  Yes 14 60.9

 Metastatectomy*
 No 7 50.0
 Yes 7 50.0

Surgical Resection Margins
 R0 36 31.3
 R1 56 48.7
 R2 18 15.7
 Unknown 5 4.30

Tumor size
 < 5 cm 9 6.87
 5 – 15 cm 62 47.3
 > 15 cm 60 45.8

Grade
 Low 23 17.6
 Moderate 27 20.6
 High 69 52.7
 Unknown 12 9.16

Number of Organs Resected
 0 21 18.3
 1–2 59 51.3
 3–4 27 23.5
 ≥ 5 8 6.96

Organ Resected
 IVC 18
 Kidney 51
 Colon 25
 Pancreas 15
 Whipple 8
 Diaphragm 5
 Spleen 11

Histology
 WDLPS 18 13.5
 DDLPS 32 24.4
 Leiomyosarcoma 52 39.7
 MPNST 5 3.80
 Angiosarcoma 4 3.00
 Synovial Cell Sarcoma 4 3.00
 MSFT 3 2.30
 Myxoid liposarcoma 1 0.75
 Rhabdomyosarcoma 1 0.75
 Fibrosarcoma 1 0.75
 Sarcoma NOS 10 7.6
*

Metastatectomy performed in patients with metastases who underwent surgery

WDLPS – Well Differentiated Liposarcoma; DDLPS – DeDifferentiated Liposarcoma MPNST – Malignant peripheral nerve sheath tumor; MSFT – Malignant Solitary Fibrous Tumor